{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T19:28:03Z","timestamp":1754162883215,"version":"3.41.2"},"reference-count":66,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,8]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>Recognition of skin findings associated with tumor predisposition syndromes can prompt early evaluation and surveillance and improve management. Additionally, knowing when to test and when to defer performing genetic testing can streamline management. This article reviews tumor predisposition syndromes with recently characterized skin findings and disorders for which early recognition and counseling can impact the course of disease.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>Caf\u00e9 au lait macules (CALMs) are important in many tumor predisposition syndromes, and \u2018atypical\u2019 CALMs are associated with constitutional mismatch repair deficiency and Fanconi anemia. Melanoma predisposition syndromes caused by pathogenic variants in <jats:italic toggle=\"yes\">POT1<\/jats:italic> and <jats:italic toggle=\"yes\">BAP1<\/jats:italic> are more recently described, and both are associated with Spitzoid tumors. Somatic pathogenic variants can cause segmental nevoid basal cell carcinoma syndrome and a mosaic form of Peutz\u2013Jeghers syndrome. Patients with PTEN hamartoma syndrome have increased risk for melanoma but this might not occur until adulthood.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>The cutaneous manifestations of tumor predisposition syndromes can aid diagnosis. Early photoprotection is key to modifying a main risk factor for skin cancer in many of these syndromes. Implementing surveillance guidelines facilitates early detection of tumors.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mop.0000000000001144","type":"journal-article","created":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T02:01:54Z","timestamp":1657850514000},"page":"349-358","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Tumor predisposition: what's the skin got to do with it?"],"prefix":"10.1097","volume":"34","author":[{"given":"Andrea","family":"Stacy","sequence":"first","affiliation":[{"name":"Division of Genetics and Genomic Medicine, Department of Pediatrics"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marwan","family":"Shinawi","sequence":"additional","affiliation":[{"name":"Division of Genetics and Genomic Medicine, Department of Pediatrics"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carrie C.","family":"Coughlin","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Departments of Medicine and Pediatrics, Washington University School of Medicine in St. Louis, St. Louis, Missouri, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250730","article-title":"BAP1 tumor predisposition syndrome","author":"Pilarski","year":"1993","journal-title":"GeneReviews((R))"},{"key":"R2-20250730","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1001\/jamadermatol.2017.2330","article-title":"Genotypic and Phenotypic Features of BAP1 Cancer Syndrome","volume":"153","author":"Haugh","year":"2017","journal-title":"JAMA Dermatol"},{"key":"R3-20250730","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1097\/DAD.0000000000001719","article-title":"Histologically diverse BAP1-deficient melanocytic tumors in a patient with BAP1 tumor predisposition syndrome","volume":"42","author":"Louw","year":"2020","journal-title":"Am J Dermatopathol"},{"key":"R4-20250730","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3390\/genes13010010","article-title":"Gene expression and mutational profile in BAP-1 inactivated melanocytic lesions of progressive malignancy from a patient with multiple lesions","volume":"13","author":"Zhou","year":"2021","journal-title":"Genes (Basel)"},{"key":"R5-20250730","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1097\/DAD.0000000000001740","article-title":"RAF1 gene fusions as a possible driver mechanism in rare BAP1-inactivated melanocytic tumors: a report of 2 cases","volume":"42","author":"Donati","year":"2020","journal-title":"Am J Dermatopathol"},{"key":"R6-20250730","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.jdcr.2020.04.018","article-title":"An adolescent with uveal melanoma and BAP1 tumor predisposition syndrome","volume":"6","author":"Young","year":"2020","journal-title":"JAAD Case Rep"},{"key":"R7-20250730","doi-asserted-by":"crossref","first-page":"721712","DOI":"10.3389\/fonc.2021.721712","article-title":"Germline BAP1 mutation in a family with multi-generational meningioma with rhabdoid features: a case series and literature review","volume":"11","author":"Prasad","year":"2021","journal-title":"Front Oncol"},{"key":"R8-20250730","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ajhg.2021.12.011","article-title":"Rare germline heterozygous missense variants in BRCA1-associated protein 1, BAP1, cause a syndromic neurodevelopmental disorder","volume":"109","author":"Kury","year":"2022","journal-title":"Am J Hum Genet"},{"key":"R9-20250730","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1093\/jnci\/djy171","article-title":"Comprehensive study of the clinical phenotype of germline BAP1 variant-carrying families worldwide","volume":"110","author":"Walpole","year":"2018","journal-title":"J Natl Cancer Inst"},{"key":"R10-20250730","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1200\/CCI.20.00124","article-title":"Microsimulation model for evaluating the cost-effectiveness of surveillance in BAP1 pathogenic variant carriers","volume":"5","author":"Walpole","year":"2021","journal-title":"JCO Clin Cancer Inform"},{"key":"R11-20250730","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1136\/jmedgenet-2014-102284","article-title":"Diagnostic criteria for constitutional mismatch repair deficiency syndrome: suggestions of the European consortium \u2019care for CMMRD\u2019 (C4CMMRD)","volume":"51","author":"Wimmer","year":"2014","journal-title":"J Med Genet"},{"key":"R12-20250730","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1136\/jmedgenet-2020-107627","article-title":"Diagnostic criteria for constitutional mismatch repair deficiency (CMMRD): recommendations from the international consensus working group","volume":"59","author":"Aronson","year":"2022","journal-title":"J Med Genet"},{"key":"R13-20250730","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1007\/s00381-020-04986-9","article-title":"Constitutional mismatch repair deficiency (CMMRD) presenting with high-grade glioma, multiple developmental venous anomalies and malformations of cortical development-a multidisciplinary\/multicentre approach and neuroimaging clues to clinching the diagnosis","volume":"37","author":"Chhabda","year":"2021","journal-title":"Childs Nerv Syst"},{"key":"R14-20250730","doi-asserted-by":"crossref","first-page":"e185","DOI":"10.1111\/bjd.15532","article-title":"Atypical dermal melanocytosis: a diagnostic clue in constitutional mismatch repair deficiency syndrome","volume":"177","author":"Polubothu","year":"2017","journal-title":"Br J Dermatol"},{"key":"R15-20250730","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1136\/jmedgenet-2015-103299","article-title":"Constitutional mismatch repair deficiency syndrome: clinical description in a French cohort","volume":"52","author":"Lavoine","year":"2015","journal-title":"J Med Genet"},{"key":"R16-20250730","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1158\/1078-0432.CCR-17-0574","article-title":"Clinical management and tumor surveillance recommendations of inherited mismatch repair deficiency in childhood","volume":"23","author":"Tabori","year":"2017","journal-title":"Clin Cancer Res"},{"key":"R17-20250730","doi-asserted-by":"crossref","first-page":"893","DOI":"10.24953\/turkjped.2021.05.017","article-title":"Cancer and constitutional Mismatch Repair Deficiency syndrome due to homozygous MSH 6 mutation in children with Cafe au Lait Spots and review of literature","volume":"63","author":"Ozyoruk","year":"2021","journal-title":"Turk J Pediatr"},{"key":"R18-20250730","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s12920-021-01031-9","article-title":"Diagnostic challenges in a CMMRD patient with a novel mutation in the PMS2 gene: a case report","volume":"14","author":"Tan","year":"2021","journal-title":"BMC Med Genomics"},{"key":"R19-20250730","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/pde.14861","article-title":"Eruptive nevi in a patient with constitutional mismatch repair deficiency (CMMRD)","volume":"39","author":"Vassantachart","year":"2022","journal-title":"Pediatr Dermatol"},{"key":"R20-20250730","article-title":"Fanconi anemia","author":"Mehta","year":"1993","journal-title":"GeneReviews((R))"},{"year":"2020","key":"R21-20250730","article-title":"Fanconi anemia clinical care guidelines."},{"key":"R22-20250730","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1158\/1078-0432.CCR-17-0465","article-title":"Recommendations for childhood cancer screening and surveillance in DNA repair disorders","volume":"23","author":"Walsh","year":"2017","journal-title":"Clin Cancer Res"},{"key":"R23-20250730","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.jaad.2020.08.047","article-title":"Cutaneous findings in Fanconi anemia","volume":"85","author":"Ruggiero","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"R24-20250730","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jaad.2021.01.029","article-title":"Skin cancer and sun protection practices in Fanconi anemia patients: a cross-sectional study","volume":"86","author":"Ruggiero","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"R25-20250730","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1038\/s41409-021-01441-4","article-title":"Long-term skin findings in patients with Fanconi anemia after allogeneic hematopoietic stem cell transplantation","volume":"56","author":"Akdogan","year":"2021","journal-title":"Bone Marrow Transplant"},{"key":"R26-20250730","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.bbmt.2016.01.023","article-title":"Late Effects surveillance recommendations among survivors of childhood hematopoietic cell transplantation: a children's oncology group report","volume":"22","author":"Chow","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"R27-20250730","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13023-020-01653-9","article-title":"Hereditary leiomyomatosis and renal cell carcinoma: a case series and literature review","volume":"16","author":"Chayed","year":"2021","journal-title":"Orphanet J Rare Dis"},{"key":"R28-20250730","article-title":"FH tumor predisposition syndrome","author":"Kamihara","year":"1993","journal-title":"GeneReviews((R))"},{"key":"R29-20250730","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.1158\/1078-0432.CCR-17-0629","article-title":"PTEN, DICER1, FH, and their associated tumor susceptibility syndromes: clinical features, genetics, and surveillance recommendations in childhood","volume":"23","author":"Schultz","year":"2017","journal-title":"Clin Cancer Res"},{"key":"R30-20250730","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s10689-019-00155-3","article-title":"Renal cell carcinoma in young FH mutation carriers: case series and review of the literature","volume":"19","author":"Hol","year":"2020","journal-title":"Fam Cancer"},{"key":"R31-20250730","article-title":"Basal cell nevus syndrome: an update on clinical findings","author":"Fernandez","year":"2021","journal-title":"Int J Dermatol"},{"key":"R32-20250730","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/bjd.20700","article-title":"A guideline for the clinical management of basal cell naevus syndrome (Gorlin-Goltz syndrome)","volume":"186","author":"Verkouteren","year":"2022","journal-title":"Br J Dermatol"},{"key":"R33-20250730","doi-asserted-by":"crossref","first-page":"103842","DOI":"10.1016\/j.ejmg.2020.103842","article-title":"Gorlin-like phenotype in a patient with a PTCH2 variant of uncertain significance","volume":"63","author":"Casano","year":"2020","journal-title":"Eur J Med Genet"},{"key":"R34-20250730","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1002\/ajmg.a.62224","article-title":"Microdeletion of 9q22.3: A patient with minimal deletion size associated with a severe phenotype","volume":"185","author":"Ewing","year":"2021","journal-title":"Am J Med Genet A"},{"key":"R35-20250730","first-page":"212","article-title":"Happle-Tinschert, Curry-Jones and segmental basal cell naevus syndromes, overlapping disorders caused by somatic mutations in hedgehog signalling genes: the mosaic hedgehog spectrum","volume":"182","author":"Lovgren","year":"2020","journal-title":"Br J Dermatol"},{"key":"R36-20250730","article-title":"SUFU haploinsufficiency causes a recognisable neurodevelopmental phenotype at the mild end of the Joubert syndrome spectrum","author":"Serpieri","year":"2021","journal-title":"J Med Genet"},{"key":"R37-20250730","doi-asserted-by":"crossref","first-page":"19791","DOI":"10.1038\/s41598-021-98752-9","article-title":"Proposed criteria for nevoid basal cell carcinoma syndrome in children assessed using statistical optimization","volume":"11","author":"Gold","year":"2021","journal-title":"Sci Rep"},{"key":"R38-20250730","article-title":"Nevoid basal cell carcinoma syndrome","author":"Evans","year":"1993","journal-title":"GeneReviews((R))"},{"key":"R39-20250730","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jdin.2021.07.003","article-title":"Pediatric basal cell carcinoma burden and management preferences in Gorlin syndrome: a survey study","volume":"5","author":"Neale","year":"2021","journal-title":"JAAD Int"},{"key":"R40-20250730","doi-asserted-by":"crossref","first-page":"3870","DOI":"10.3390\/cancers13153870","article-title":"Review of the molecular genetics of basal cell carcinoma; inherited susceptibility, somatic mutations, and targeted therapeutics","volume":"13","author":"Kilgour","year":"2021","journal-title":"Cancers (Basel)"},{"key":"R41-20250730","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s10689-021-00247-z","article-title":"Current recommendations for cancer surveillance in Gorlin syndrome: a report from the SIOPE host genome working group (SIOPE HGWG)","volume":"20","author":"Guerrini-Rousseau","year":"2021","journal-title":"Fam Cancer"},{"key":"R42-20250730","article-title":"Peutz-Jeghers syndrome","author":"McGarrity","year":"1993","journal-title":"GeneReviews((R))"},{"key":"R43-20250730","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/MPG.0000000000002248","article-title":"Management of Peutz-Jeghers syndrome in children and adolescents: a position paper from the ESPGHAN Polyposis Working Group","volume":"68","author":"Latchford","year":"2019","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R44-20250730","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s10689-020-00191-4","article-title":"Two cases of somatic STK11 mosaicism in Danish patients with Peutz-Jeghers syndrome","volume":"20","author":"Jelsig","year":"2021","journal-title":"Fam Cancer"},{"key":"R45-20250730","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1634\/theoncologist.2019-0846","article-title":"Emerging therapeutic implications of STK11 mutation: case series","volume":"25","author":"Laderian","year":"2020","journal-title":"Oncologist"},{"key":"R46-20250730","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.3892\/etm.2021.10823","article-title":"Peutz-Jeghers syndrome: skin manifestations and endocrine anomalies (Review)","volume":"22","author":"Sandru","year":"2021","journal-title":"Exp Ther Med"},{"key":"R47-20250730","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.pathol.2021.08.009","article-title":"Gastrointestinal polyposis with associated cutaneous manifestations","volume":"54","author":"Duarte","year":"2022","journal-title":"Pathology"},{"key":"R48-20250730","doi-asserted-by":"crossref","first-page":"473","DOI":"10.3390\/jcm10030473","article-title":"The management of Peutz-Jeghers syndrome: European Hereditary Tumour Group (EHTG) Guideline","volume":"10","author":"Wagner","year":"2021","journal-title":"J Clin Med"},{"key":"R49-20250730","doi-asserted-by":"crossref","first-page":"5121","DOI":"10.3390\/cancers13205121","article-title":"Peutz-Jeghers syndrome and the role of imaging: pathophysiology, diagnosis, and associated cancers","volume":"13","author":"Klimkowski","year":"2021","journal-title":"Cancers (Basel)"},{"key":"R50-20250730","article-title":"POT1 tumor predisposition","author":"Henry","year":"1993","journal-title":"GeneReviews((R))"},{"key":"R51-20250730","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/ng.2941","article-title":"Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma","volume":"46","author":"Shi","year":"2014","journal-title":"Nat Genet"},{"key":"R52-20250730","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.jaad.2020.03.100","article-title":"Histologic features of melanoma associated with germline mutations of CDKN2A, CDK4, and POT1 in melanoma-prone families from the United States, Italy, and Spain","volume":"83","author":"Sargen","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"R53-20250730","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/jdv.17735","article-title":"Melanoma in children and adolescents: analysis of susceptibility genes in 123 Italian patients","volume":"36","author":"Pellegrini","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R54-20250730","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1136\/jmedgenet-2020-107098","article-title":"Loss-of-function variants in POT1 predispose to uveal melanoma","volume":"58","author":"Nathan","year":"2021","journal-title":"J Med Genet"},{"key":"R55-20250730","article-title":"PTEN Hamartoma tumor syndrome","author":"Yehia","year":"1993","journal-title":"GeneReviews((R))"},{"key":"R56-20250730","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1172\/JCI121277","article-title":"PTEN-opathies: from biological insights to evidence-based precision medicine","volume":"129","author":"Yehia","year":"2019","journal-title":"J Clin Invest"},{"key":"R57-20250730","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1093\/hmg\/ddab094","article-title":"mTOR inhibitors reduce enteropathy, intestinal bleeding and colectomy rate in patients with juvenile polyposis of infancy with PTEN-BMPR1A deletion","volume":"30","author":"Taylor","year":"2021","journal-title":"Hum Mol Genet"},{"key":"R58-20250730","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1634\/theoncologist.2019-0514","article-title":"A pilot study of sirolimus in subjects with cowden syndrome or other syndromes characterized by germline mutations in PTEN","volume":"24","author":"Komiya","year":"2019","journal-title":"Oncologist"},{"key":"R59-20250730","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1038\/s41431-020-0651-7","article-title":"Cancer Surveillance Guideline for individuals with PTEN hamartoma tumour syndrome","volume":"28","author":"Tischkowitz","year":"2020","journal-title":"Eur J Hum Genet"},{"key":"R60-20250730","article-title":"Characterizing dermatologic findings among patients with PTEN hamartoma tumor syndrome: results of a multicenter cohort study","author":"Morgan","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"R61-20250730","doi-asserted-by":"crossref","first-page":"e98","DOI":"10.1158\/1078-0432.CCR-17-0652","article-title":"Retinoblastoma and neuroblastoma predisposition and surveillance","volume":"23","author":"Kamihara","year":"2017","journal-title":"Clin Cancer Res"},{"key":"R62-20250730","article-title":"Retinoblastoma","author":"Lohmann","year":"1993","journal-title":"GeneReviews((R))"},{"key":"R63-20250730","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1016\/j.jmoldx.2021.08.014","article-title":"Highly sensitive detection method of retinoblastoma genetic predisposition and biomarkers","volume":"23","author":"Le Gall","year":"2021","journal-title":"J Mol Diagn"},{"key":"R64-20250730","doi-asserted-by":"crossref","first-page":"e2022126","DOI":"10.1001\/jamanetworkopen.2020.22126","article-title":"Incidence and mortality of second primary cancers in danish patients with retinoblastoma, 1943\u20132013","volume":"3","author":"Gregersen","year":"2020","journal-title":"JAMA Netw Open"},{"key":"R65-20250730","doi-asserted-by":"crossref","first-page":"2849.e3","DOI":"10.1016\/j.jid.2021.05.021","article-title":"Increased risk of skin cancer in 1,851 long-term retinoblastoma survivors","volume":"141","author":"Kleinerman","year":"2021","journal-title":"J Invest Dermatol"},{"key":"R66-20250730","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/j.ophtha.2020.05.024","article-title":"Recommendations for long-term follow-up of adults with heritable retinoblastoma","volume":"127","author":"Tonorezos","year":"2020","journal-title":"Ophthalmology"}],"container-title":["Current Opinion in Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0000000000001144","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T18:13:00Z","timestamp":1753899180000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0000000000001144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":66,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/mop.0000000000001144","relation":{},"ISSN":["1040-8703","1531-698X"],"issn-type":[{"type":"print","value":"1040-8703"},{"type":"electronic","value":"1531-698X"}],"subject":[],"published":{"date-parts":[[2022,8]]}}}